Mayak

Russian breeding excellence for herbal industry

The Inula helenium variety 'Mayak' represents a significant achievement of the A.K. Chayka Federal Research Center of Agrobiotechnologies of the Far East. Developed to meet the rigorous demands of the pharmaceutical market, this variety stands out as a highly specialized crop designed for consistent raw material production in the herbal medicine sector.

Agronomic performance and industrial value

The primary focus of the 'Mayak' variety is the efficient accumulation of inulin, the core active compound that determines the medical value of Inula roots. Beyond its chemical profile, the variety is engineered for uniformity, which is vital for the mechanization of the harvesting process—a traditional bottleneck in large-scale herbal farming.

• Originator: A.K. Chayka Federal Research Center of Agrobiotechnologies of the Far East.
• Crop Type: Medicinal plant (Elecampane/Inula).
• Key Market Asset: Predictable chemical composition and high root yield.

In the field, 'Mayak' demonstrates excellent resilience against common pathogens, reducing the necessity for intensive chemical intervention. For commercial growers focusing on niche medicinal plants, this variety offers a reliable return on investment: the stable quality of the root harvest ensures continuous demand from pharmaceutical manufacturers who operate under strict quality control protocols.